David Gilmore

SNMMI-TS Plenary Session — Beyond the Bot

Abstract placeholder. Drop in the official SNMMI session abstract once published.

Day and time to be confirmed against the SNMMI program.

1. How much of the AI tooling on the floor would you trust in a regulated reading workflow today?
2. Which Actinium-225 program is the one you'd actually bet on, and why?
3. How is your team thinking about the cyclotron-versus-reactor tradeoff for short-half-life isotopes?

Generated by a mock model. Wired to Anthropic when the API key is in place.

What we're seeing

• BioPharma Reporter · 2026-02-23
  David Gilmore delivers keynote at International Theranostics Congress
  The announcement comes amid tightening Mo-99 and Lu-177 supply.
• FierceBiotech · 2026-09-16
  David Gilmore comments on FDA guidance for radiopharmaceutical trials
  Coverage notes the company's growing footprint in the radioligand therapy space.
• Endpoints News · 2026-08-13
  David Gilmore co-authors review on PSMA in Journal of Nuclear Medicine
  The work builds on more than a decade of radiochemistry collaboration.
• Reuters Health · 2026-07-18
  David Gilmore presents updated trial data at ASCO Annual Meeting
  Details remain limited but analysts read the move as a positioning play ahead of pivotal data.
• PR Newswire · 2026-06-11
  David Gilmore joins editorial board of European Journal of Nuclear Medicine
  Details remain limited but analysts read the move as a positioning play ahead of pivotal data.

Mocked while we wire the Exa integration. Headlines are illustrative.